 |
|
|
Margaret Haney, PH.D.
Professor of Clinical Neuroscience (in Psychiatry)
Director of Marijuana Research Laboratory,
New York State Psychiatric Institute
Associate Director of the Substance Use Research Center,
|
|
|
|
|
|
|
|
|
Dr. Margaret (Meg) Haney is a Professor of Clinical Neuroscience, and Co-Director of the Substance Use Research Center at Columbia University. Her research focuses on the consequences of chronic marijuana use, as well as the development of novel approaches for the treatment of cocaine and marijuana dependence. An additional interest is the potential therapeutic effects of marijuana and other cannabinoids in HIV+ populations. Dr. Haney is an author of more than 90 articles in peer-reviewed journals, acts as an advisory editor for Psychopharmacology, and has been a member of a NIDA review group.
|
 |
Undergraduate: Rutgers College, B.S., 1981-1985
Graduate: Tufts University, M.A., Ph.D., 1985-1992
|
 |
• Drug Dependence
|
 |
|
Phone: 212-543-6539
Fax: 212-543-5991
|
 |
| I am interested in characterizing and developing treatments for marijuana dependence as well as cocaine dependence.
|
 |
1. Haney M, Spealman R: Controversies in translational research: Drug self-administration, Invited Review. Psychopharmacology 2008;199: 403-419
2. Haney M, Gunderson EW, Rabkin J, Hart CL, Vosburg SK, Comer SD, Foltin RW: Dronabinol and marijuana in HIV+ marijuana smokers: Caloric intake, mood and sleep. JAIDS 2007;32: 1391-1403
3. Haney M: Neurobiology of Stimulants, M Galanter, HD Kleber (Eds.), Textbook of Substance Abuse: 4th Edition., Washington, DC, USA, 2008
4. Haney M, Hart CL, Vosburg SK, Comer SD, Collins Reed S, Foltin RW: Effects of THC and lofexidine in a human laboratory model of marijuana withdrawal and relapse. Psychopharmacology 2008;197: 157-168
5. Haney M, Ward AS, Foltin RW, Fischman MW: Effects of ecopipam, a selective dopamine D1 antagonist, on smoked cocaine self-administration by humans. Psychopharmacology 2001;155: 330-337
|
 |
|
FACULTY ONLY
|
|
|
